Cuatrecasas advised Invivo Capital, Advent Biotechnology and Takeda Ventures on the round of financing in Integra Therapeutics. At closure of the transaction, the spin-off of Universitat...
Integra Therapeutics’ €4.5 Million Financing Round
Advent France Biotechnology’s €86 Million Fund Closing
IN BRIEF: Chammas & Marcheteau, advised on the matter. Chammas & Marcheteau advised Advent France Biotechnology SAS with a team including Christophe Moreau (Picture – Tax...